HiBob
HiBob develops Bob, a cloud people-management platform for growing and multinational companies.
$166MSeries F
ParticipantFC
Farallon Capital Management
Activity from announced rounds
Activity in this selectionUnited Kingdom · Oct 12, 2026 · Jan 1, 2026
Farallon Capital Management is the investment manager identified by Encoded Therapeutics and HiBob, with Farallon also used as a short name.
Recorded funding activity
Encoded develops precision gene therapies for neurological disorders. HiBob supplies the Bob people-management platform, while Mirador develops medicines for inflammatory and fibrotic diseases. Their financing events retain the same manager identity without collapsing individual funds.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $166M 1 disclosed · full round size, not this investor’s share